Latest reported quarter: Q2, ended Jun 2026
| Line item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Operating Cash Flow | $23.23M | $12.85M | $52.47M | $68.53M | $2.68M |
| Capital Expenditure | -$9.16M | -$9.73M | – | – | -$9.00M |
| Net Investment Purchase and Sale | $12.71M | -$1.52M | -$1.26M | -$1.21M | $55.56M |
| Financing Cash Flow | $1.91M | -$7.48M | -$48.31M | -$51.08M | $3.70M |
| Net Cash Flow from Continuing Financing Activities | $1.91M | -$7.48M | -$48.31M | -$51.08M | $3.70M |
| Net Common Stock Issuance | $0.00 | $0.00 | -$50.01M | -$50.00M | $0.00 |
| Proceeds from Stock Option Exercised | $2.60M | $109,000.00 | $2.40M | $347,000.00 | $5.43M |
| Net Other Financing Charges | -$685,000.00 | -$7.59M | -$694,000.00 | -$1.43M | -$1.73M |
| Ending Cash Balance | $127.76M | $98.93M | $104.81M | $112.85M | $106.93M |
| Net Cash Flow from Continuing Investing Activities | $3.55M | -$11.25M | -$11.92M | -$11.65M | $46.56M |
| Net cash flow from investing | $3.55M | -$11.25M | -$11.92M | -$11.65M | $46.56M |
| -Change in Payables and Accrued Expense | -$17.74M | -$5.19M | -$15.47M | $17.34M | $26.34M |
| Net cash flow from continuing operations | $23.23M | $12.85M | $52.47M | $68.53M | $2.68M |
| Net Income from Continuing Operations | $314,000.00 | -$11.29M | $136.09M | $9.93M | -$3.59M |
| Depreciation & Depletion & Amortization | $4.60M | $5.11M | $3.82M | $3.68M | $3.41M |
| Other Non-Cash Items | $193,000.00 | $548,000.00 | $543,000.00 | $185,000.00 | $871,000.00 |
| Change in Working Capital | -$22.83M | -$13.11M | -$26.85M | $25.44M | -$42.56M |
| -Change in Receivables | $1.93M | $14.29M | -$11.63M | $29.72M | -$44.58M |
| -Change in Inventory | -$4.22M | -$20.94M | -$3.52M | -$20.14M | -$21.91M |
| -Change in Prepaid Assets | -$2.81M | -$1.26M | $3.76M | -$1.47M | -$2.41M |
| Net Change in Cash | $28.69M | -$5.88M | -$7.76M | $5.80M | $52.94M |
| Beginning Cash Balance | $98.93M | $104.81M | $112.85M | $106.93M | $53.88M |
| Effect of Exchange Rate Changes | $142,000.00 | $1,000.00 | -$275,000.00 | $115,000.00 | $102,000.00 |
| Free Cash Flow | $14.07M | $3.12M | $41.81M | $58.09M | -$6.31M |
| Deferred Tax | $10.15M | $1.01M | – | – | $0.00 |
| Net PPE Purchase and Sale | – | – | -$10.66M | – | – |
| Line item | 2026 Q2 | 2026 Q1 | 2025 Q4 | 2025 Q3 | 2025 Q2 |
|---|---|---|---|---|---|
| Basic EPS | $0.01 | -$0.39 | $4.70 | $0.34 | -$0.12 |
| Net Income to Parent Company | $314,000.00 | -$11.29M | $136.09M | $9.93M | -$3.59M |
| Operating Expense | $171.97M | $178.03M | $186.90M | $183.08M | $185.73M |
| Gross Profit | $171.46M | $176.91M | $233.01M | $192.73M | $182.41M |
| Cost of Revenue | $29.12M | $27.67M | $36.07M | $31.77M | $34.67M |
| Total Operating Revenue | $200.58M | $204.58M | $269.08M | $224.50M | $217.09M |
| Total Revenue as Reported | $200.58M | $204.58M | $269.08M | $224.50M | $217.09M |
| Selling and Admin Expenses | $147.28M | $152.20M | $161.95M | $158.87M | $159.52M |
| Research & Development | $24.70M | $25.83M | $24.94M | $24.21M | $26.21M |
| Operating Profit | -$514,000.00 | -$1.12M | $46.11M | $9.64M | -$3.32M |
| Profit from Continuing Operations | $314,000.00 | -$11.29M | $136.09M | $9.93M | -$3.59M |
| Net Profit | $314,000.00 | -$11.29M | $136.09M | $9.93M | -$3.59M |
| Tax | $2.80M | $13.69M | -$85.77M | $3.62M | $1.26M |
| Pretax Profit | $3.12M | $2.40M | $50.32M | $13.55M | -$2.33M |
| Other Non-Operating Income (Expenses) | -$110,000.00 | -$226,000.00 | $330,000.00 | -$66,000.00 | -$3.50M |
| Other Income (Expense) | -$110,000.00 | -$226,000.00 | $330,000.00 | -$66,000.00 | -$3.50M |
| Non-Operating Interest Income | $3.74M | $3.74M | $4.00M | $3.98M | $4.48M |
| Net Non-Operating Interest Income (Expense) | $3.74M | $3.74M | $3.88M | $3.97M | $4.48M |
| Net Income to Common Stockholders | $314,000.00 | -$11.29M | $136.09M | $9.93M | -$3.59M |
| Diluted EPS | $0.01 | -$0.39 | $4.66 | $0.34 | -$0.12 |
| Non-Operating Interest Expense | – | – | $122,000.00 | $11,000.00 | – |
No comments yet — be the first to weigh in on INSP.